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A B S T R A C T
Background: Paroxysmal atrial fibrillation (AF) is associated
with significant impairment of quality of life (QoL), which
is to a large extent independent of objective measures of
disease severity. We sought to investigate the potential
role of neuroticism in the impairment of QoL in patients
with paroxysmal AF. 
Methods: The study group (AF group) comprised 73 patients
with paroxysmal AF (mean age 55.5 ± 13.3 years, 50 males).
On average, patients had a three-year history of one
symptomatic paroxysm a week lasting two hours. QoL
was assessed using the Medical Outcomes Study Short
Form (SF-36) and neuroticism was assessed using the
short-scale Eysenck Personality Questionnaire (EPQ).
Results: The degree of neuroticism in the AF patient
group did not differ from the degree of neuroticism in a
group of age- and sex-matched controls (mean EPQ score
on neuroticism 4.1 ± 3.0 and 3.9 ± 3.1, respectively; p=NS).
Within the AF group, multivariate regression analyses
showed that QoL in the physical domain (SF-36 physical
functioning, physical role function, vitality and pain
subscales) was not related the degree of neuroticism.
In contrast, significant inverse relations were observed
between scores on the mental health and social functioning
subscales and the degree of neuroticism ( coefficients
p<.05), independent of age, sex and symptoms.
Conclusion: Based on the present study, patients with
paroxysmal AF appear to have on average a degree of
neuroticism similar to age- and sex-matched controls.
However, the impairment of QoL in these patients, in
particular regarding social functioning and mental health,
seems to be related to a relatively high degree of neuroticism,
independent of age and sex.
K E Y W O R D S
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I N T R O D U C T I O N
Atrial fibrillation (AF) is a very common arrhythmia, and
its prevalence is still increasing. Two studies have recently
been published with a primary focus on the impact of
paroxysmal AF on quality of life (QoL);1,2 both studies
used the Medical Outcomes Study Short Form (SF-36).
The two studies were consistent: patients with paroxysmal
AF were characterised by rather low QoL across all domains
(physical and social functioning, and mental health)
compared with healthy controls. Of interest is that in
both studies QoL only marginally depended on objective
measures of disease severity (New York Heart Association
functional class, left ventricular function) and even
arrhythmia burden (frequency and duration of paroxysms,
as based on the history) played a minor role. Instead, it was
shown that the presence of cardiac symptoms associated
with paroxysms of AF was predictive for impaired QoL.2
For instance, chest pain and dizziness were associated with
a low score on the physical role function subscale, which
is probably not surprising. On the other hand, although
loss of QoL is greater in severely symptomatic patients,
even mildly symptomatic AF patients have a lower overall
perception of well-being (‘global life satisfaction’).3 In
conclusion, the impairment of QoL in patients with AF 
is still only partly explained, and other factors should be
considered. We hypothesised that neuroticism might be
implicated in the impairment of QoL in patients with AF.
Neuroticism is a stable personality trait, which gives an
© 2005 Van Zuiden Communications B.V. All rights reserved.
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indication of the emotional stability of a person. Persons
with high scores on neuroticism scales tend to be anxious
and to have more worries in general, and neuroticism has
proved to be an important predictor of psychological distress,
both in the presence and the absence of stressful circum-
stances.4 More specifically, persons with a high degree of
neuroticism often have vague complaints about their health,
which are not readily attributable to objective somatic
disease,5 but which may nonetheless have a negative
impact on their QoL. The aim of the present study was
to investigate the potential role of neuroticism in the
impairment of QoL in patients with paroxysmal AF. 
M A T E R I A L S  A N D  M E T H O D S
Patient selection and study design
The study group consisted of patients who had participated
in a previous study on QoL.2 Briefly, all consecutive patients
from the outpatient clinic with paroxysmal AF, aged >18
years, were considered eligible for the study. Paroxysmal
AF was defined as proposed by Gallagher and Camm:6
paroxysms had to terminate either spontaneously or after
treatment with an antiarrhythmic drug. The presence of
AF was based on electrocardiographic evidence, including
ambulatory (Holter) monitoring. Lone AF was inferred when
routine cardiac investigations (echocardiogram, ergometry)
did not reveal structural heart disease. Patients with
hypertension were considered to have structural heart
disease. In the first study2 a set of questionnaires was
administered to the patients, including questionnaires on
QoL, symptomatology and personality. Data thus collected
were entered into a database, and in the present study we
used this database focussing on personality, that is, neuroti-
cism. The study was performed in accordance with the
Declaration of Helsinki and approved by the institutional
ethics committee. Informed consent was obtained from
all patients.
Quality of life and symptomatology
Details have been described previously.2 Briefly, QoL was
measured by the SF-36,7 which is a widely used, thoroughly
validated, standardised, generic health survey, consisting
of eight subscales that measure physical functioning,
bodily pain, role limitations due to physical or emotional
problems, social functioning, as well as sense of vitality,
mental health and general health. These scales together
cover the three major domains of QoL, i.e. physical and
social functioning, and mental health. Scores of each sub-
scale are transformed to a scale ranging from 0 to 100,
with lower scores representing a lower QoL. The following
symptoms were incorporated in the analysis: palpitations,
dyspnoea, dizziness and chest pain. Patients were asked
to rate these symptoms as they occurred during AF
according to severity; none-to-mild or moderate-to-severe. 
Neuroticism
Neuroticism was assessed using the revised, short-scale
Eysenck Personality Questionnaire (EPQ), with a validated
Dutch translation (table 1).8,9 Neuroticism is quantified
using a set of 12 questions, to be answered with yes or no.
The total score thus ranges from 0 to 12, a higher score
signifying a higher degree of neuroticism. 
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Table 1
Eysenck personality questionnaire (revised, short scale)
Does your mood often go up and down? Yes No
Do you ever feel ‘just miserable’ for no reason? Yes No
Are you an irritable person? Yes No
Are your feelings easily hurt? Yes No
Do you often feel ‘fed-up’? Yes No
Would you call yourself a nervous person? Yes No
Are you a worrier? Yes No
Would you call yourself tense or ‘highly-strung’? Yes No
Do you worry too long after an embarrassing experience? Yes No
Do you suffer from ‘nerves’? Yes No
Do you often feel lonely? Yes No
Are you often troubled about feelings of guilt? Yes No
Yes = 1; No = 0. Total score is calculated by adding the scores on the individual
questions.
Data analysis
First, in order to determine the relative degree of neuroti-
cism in the AF patients, the EPQ scores on neuroticism
were compared with scores in controls individually matched
for age and sex, using t-tests for independent samples. The
control subjects were taken from a previously established
control group consisting of 849 randomly selected adults.9
The analyses were performed for the two groups as a
whole, as well as for subgroups according to age and sex.
Second, in order to determine whether (impaired) QoL
was related to the degree of neuroticism, multivariate
regression analyses were performed. For each of the four
symptoms, the independent contributions of the particular
symptom and neuroticism to the QoL scores on any of
the eight subscales were examined, thereby controlling for
age and sex. Mean values ± the standard deviation were
calculated for normally distributed variables and median
values with range were used for non-normal distributions.
A p value <0.05 was considered statistically significant.
R E S U L T S
Patient characteristics
The study group comprised 73 patients. Clinical character-
istics are given in table 2. Most patients were male and in
the majority no structural heart disease was apparent
(lone AF). Almost half of the patients with structural
heart disease had hypertension. None of the patients had
congestive heart failure. Mean echo parameters were
within the normal range. Self-reported arrhythmia burden
in terms of the duration of the paroxysms ranged from
15 minutes to two days, whereas the frequency ranged from
two paroxysms a year to five a week. On average, patients
had a three-year history of one paroxysm a week lasting
two hours. Most patients (70%) were on an antiarrhythmic
agent to suppress their arrhythmia (‘rhythm control’),
whereas the remaining patients (30%) were not taking any
medications or only medication for control of ventricular
rate during AF (‘rate control’). 
Neuroticism
All patients fully completed and returned the question-
naires. Mean total score in the AF group was 4.1 ± 3.0 and
mean total score in the control group was 3.9 ± 3.1, the
difference not being statistically significant. Also in the
subgroups according to mean age and sex no statistically
significant differences were found between the AF group
and the control group. These data imply that the degree
of neuroticism in the AF patients was similar to that in
the controls.
Symptoms, neuroticism and quality of life
Regression coefficients indicating the independent relation
between symptoms and neuroticism on the one hand and
the eight QoL scales on the other, for each symptom
separately, are presented in table 3. In the physical domain
(physical functioning, physical role function, vitality and
pain subscales) impaired QoL was significantly related to
symptom severity for almost all symptoms ( coefficients
p<0.05), but not to the degree of neuroticism. For example,
scores on physical functioning were lower in the patients
with moderate-to-severe palpitations as opposed to patients
with none-to-mild palpitations ( coefficient -0.26, p=0.01),
whereas the degree of neuroticism did not play a role 
( coefficient -0.03, p=0.81). In contrast, significant inverse
relations were observed between scores on the mental
health and social functioning subscales and the degree of
neuroticism ( coefficients p<.05), whereas in this instance
QoL was not related the severity of any of the symptoms.
For example, scores on mental health did not differ in the
patients with moderate-to-severe palpitations as opposed to
patients with none-to-mild palpitations ( coefficient -0.01,
p=0.95). Instead, scores on mental health were significantly
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Age (years) ± SD 55.5 ± 13.3
Sex
Male (%) 50 (68)
Female (%) 23 (32)
Underlying heart disease
Ischaemic heart disease (%) 12 (16)
Valvular heart disease (%) 7 (10)
Hypertension (%) 11 (15)
Lone atrial fibrillation (%) 43 (59)
Arrhythmia burden
Total duration (years) (range) 3.0 (0.2-30)
Frequency of paroxysms/week (range) 1.00 (0.04-5)
Duration of paroxysms (hours) (range) 2.00 (0.15-48)
Echo parameters
Left ventricular end-diastolic dimension (mm) 47 ± 5
Left ventricular end-systolic dimension (mm) 32 ± 6
Left atrial dimension, parasternal (mm) 35 ± 6
Left atrial dimension, apical (mm) 54 ± 7
Medication
Class I antiarrhythmics (%) 27 (37)
Class III antiarrhythmics (%) 24 (33)
Beta-blockers (%) 25 (34)
Digoxin (%) 7 (10)
No medication (%) 17 (23)
Table 3
Relation of QoL with symptoms and neuroticism 
PHYSICAL SOCIAL PHYSICAL EMOTIONAL MENTAL VITALITY PAIN GENERAL
FUNCTION- FUNCTION- ROLE ROLE HEALTH HEALTH
ING ING FUNCTION FUNCTION
 P  P  P  P  P  P  P  P
Palpitations Neuroticism -.03 .81 -.39 <.01 -.07 .53 -.19 .12 -.74 <.01 -.02 .89 .06 .59 -.09 .44
Palpitations -.26 .01 .05 .69 -.27 .02 -.17 .17 -.01 .95 -.38 .07 -.18 .13 -.08 .48
Dyspnoea Neuroticism -.09 .36 -.39 <.01 -.16 .15 -.23 .06 -.74 <.01 -.28 0.2 .01 .92 -.12 .30
Dyspnoea -.26 .01 -.07 .55 -.43 <.01 -.12 .31 -.07 .43 -.32 <.01 -.28 .02 -.16 .16
Dizziness Neuroticism -.02 .86 -.35 <.01 -.06 .61 -.18 .14 -.70 <.01 -.25 .04 .06 .59 -.07 .56
Dizziness -.26 .02 -.16 .17 -.31 <.01 -.20 .10 -.19 .03 -.16 .18 -.18 .12 -.19 .10
Chest pain Neuroticism -.04 .68 -.21 .12 -.10 .41 -.20 .10 -58 <.01 -.25 .04 .08 .48 -.09 .43
Chest pain -.33 <.01 .10 .59 -.28 .02 -.21 .09 .19 .16 -.25 .04 -.39 <.01 -.16 .17
Each symptom was dichotomised according to severity (none-to-mild or moderate-to-severe).  =  coefficient; p = p value.
lower when the degree of neuroticism was higher 
( coefficient -0.74, p<0.01). Regarding the emotional
role function subscale, the results varied, both symptoms
and neuroticism being implicated in some but not all
instances. Finally, no relation was observed between general
health and neuroticism nor between general health and
symptoms. 
D I S C U S S I O N
Main findings
In the present study, patients with paroxysmal AF were
found to have on average a degree of neuroticism similar
to age- and sex-matched controls. However, within the
group of AF patients, impairment of QoL, in particular
regarding social functioning and mental health, was related
to a higher degree of neuroticism, independent of age
and sex.
Atrial fibrillation and personality
The role of personality in patients with coronary artery
disease is an issue of ongoing debate.10,11 However, studies
regarding personality and cardiac disorders other than
coronary artery disease are scarce. In particular, to our
knowledge no data are available on neuroticism in patients
with AF, despite the fact that AF is rapidly becoming a
major health problem associated with substantial morbidity
and mortality. Perhaps based on clinical experience with
individual patients one might intuitively surmise that
patients with paroxysmal AF have on average a higher
degree of neuroticism than other persons. However, the
results of our study clearly indicate that this is not the case;
although the EPQ scores on neuroticism differed among
the individual patients, including some patients with high
scores, mean score in the group as a whole was similar
to the mean score in the group of age- and sex-matched
controls. In other words, patients with paroxysmal AF
would on average appear to have a ‘normal’ degree of
neuroticism. 
Quality of life and neuroticism
Notwithstanding the observation that patients with paroxys-
mal AF have on average a normal degree of neuroticism,
it would be conceivable that patients with paroxysmal AF
with a higher degree of neuroticism suffer from an even
lower QoL than patients with a lower degree of neuroticism.
Unlike the more physical domain of QoL, in the domains
of social functioning and mental health a high degree of
neuroticism was indeed found to be related to a low QoL.
In more practical terms this finding implies that patients
with a high degree of neuroticism experience poor social
functioning and mental health, irrespective of the presence
of the physical symptoms associated with their arrhythmia.
In other words, whether or not the patient suffers from
palpitations (or other symptoms), social functioning and
mental health are likely to be poor if the patient has a
high degree of neuroticism. Extending this concept even
further, it may even be surmised that the presence or
absence of AF as such is irrelevant, patients with a high
degree of neuroticism experience poor social functioning
and mental health anyway. Our study also provides a likely
explanation for the finding in a previous study on QoL in
patients with AF by Paquette et al.12 By using the Barsky
Somatosensory Amplification Scale, they investigated the
tendency of AF patients to somatise, i.e. to amplify
benign bodily sensations, and they showed that a high
tendency to somatise predicted a poor QoL. Since the
tendency to somatise is one of the established features of
neuroticism,5 it is readily conceivable that neuroticism
was the actual underlying personality disorder in these
patients. 
Methodological considerations
In the present study we assessed the relation between
neuroticism and QoL. The analysis was corrected for age
and sex, but we did not incorporate measures on structural
heart disease and arrhythmia burden. Also, medication
(in particular antiarrhythmic agents) was not incorporated
in the analysis. However, these factors have previously
been shown to have only a minor effect (at the most) on
QoL.1,2 Another consideration concerns the possibility that
personality was affected by paroxysmal AF. In particular,
it is intuitively conceivable that the degree of neuroticism
would increase over time, secondary to the illness. However,
as a constitutional entity, personality is stable over time,
and life events (including somatic disease) do not signifi-
cantly affect personality.13 Moreover, the fact that the
degree of neuroticism in patients with AF was not higher
than in controls argues against such an effect. Finally,
this study was not designed to determine whether the
patients were ‘neurotic’ in terms of a psychiatric disorder.
Instead, the concept of neuroticism was used to describe
a normal variant of human personality, and the results of
our study merely indicate that the impairment of QoL in
patients with paroxysmal AF is related to the relative
degree of neuroticism, patients with a relatively high
degree of neuroticism suffering from a lower QoL than
patients with a lower degree of neuroticism. 
Possible implications
Previous studies have shown that treatment of patients
with paroxysmal AF, either with medication14 or ablation
techniques15,16 leads to improvement of QoL. However,
despite significant reduction of arrhythmia burden, not
all patients obtained benefit from treatment in terms of
QoL. Given the results of our study, it is conceivable that
differences in the degree of neuroticism between the
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patients played a critical role in this connection, patients
with a high degree of neuroticism benefiting less from
treatment. As a practical implication, our findings suggest
that when treating patients with paroxysmal AF one should
take into consideration whether the patient has a high
degree of neuroticism or not. If so, the goal of treatment
in terms of improvement of QoL should probably be not
too high, at least not regarding social functioning and
mental health. 
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